Akcea and Ionis Receive Complete Response Letter for Waylivra from FDA

CAMBRIDGE, Mass. and CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA) an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), today announced that they received a Complete...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news